Annual CFI
$77.79 M
-$51.85 M-40.00%
December 1, 2024
Summary
- As of March 12, 2025, ADPT annual cash flow from investing activities is $77.79 million, with the most recent change of -$51.85 million (-40.00%) on December 1, 2024.
- During the last 3 years, ADPT annual CFI has fallen by -$103.42 million (-57.07%).
- ADPT annual CFI is now -57.07% below its all-time high of $181.21 million, reached on December 31, 2021.
Performance
ADPT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$22.12 M
+$16.83 M+318.37%
December 1, 2024
Summary
- As of March 12, 2025, ADPT quarterly cash flow from investing activities is $22.12 million, with the most recent change of +$16.83 million (+318.37%) on December 1, 2024.
- Over the past year, ADPT quarterly CFI has increased by +$16.83 million (+318.37%).
- ADPT quarterly CFI is now -87.54% below its all-time high of $177.49 million, reached on June 30, 2020.
Performance
ADPT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$77.79 M
+$18.91 M+32.12%
December 1, 2024
Summary
- As of March 12, 2025, ADPT TTM cash flow from investing activities is $77.79 million, with the most recent change of +$18.91 million (+32.12%) on December 1, 2024.
- Over the past year, ADPT TTM CFI has increased by +$18.91 million (+32.12%).
- ADPT TTM CFI is now -71.15% below its all-time high of $269.69 million, reached on September 30, 2020.
Performance
ADPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ADPT Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -40.0% | +318.4% | +32.1% |
3 y3 years | -57.1% | +366.1% | -12.0% |
5 y5 years | +116.2% | +366.1% | -12.0% |
ADPT Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -57.1% | +2577.9% | -67.1% | +122.7% | -57.1% | +2577.9% |
5 y | 5-year | -57.1% | +116.2% | -87.5% | +106.5% | -71.2% | +116.2% |
alltime | all time | -57.1% | +116.2% | -87.5% | +106.5% | -71.2% | +115.5% |
Adaptive Biotechnologies Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $77.79 M(-40.0%) | $22.12 M(+318.4%) | $77.79 M(+32.1%) |
Sep 2024 | - | $5.29 M(-10.0%) | $58.88 M(-26.2%) |
Jun 2024 | - | $5.88 M(-86.8%) | $79.73 M(-28.3%) |
Mar 2024 | - | $44.51 M(+1287.9%) | $111.18 M(-14.2%) |
Dec 2023 | $129.65 M(+4362.9%) | $3.21 M(-87.7%) | $129.65 M(+348.7%) |
Sep 2023 | - | $26.14 M(-30.0%) | $28.90 M(-52.5%) |
Jun 2023 | - | $37.32 M(-40.7%) | $60.77 M(+115.5%) |
Mar 2023 | - | $62.98 M(-164.6%) | $28.20 M(+870.6%) |
Dec 2022 | $2.90 M(-98.4%) | -$97.54 M(-268.1%) | $2.90 M(-98.3%) |
Sep 2022 | - | $58.02 M(+1122.4%) | $167.66 M(+89.7%) |
Jun 2022 | - | $4.75 M(-87.4%) | $88.38 M(-29.3%) |
Mar 2022 | - | $37.69 M(-43.9%) | $125.08 M(-31.0%) |
Dec 2021 | $181.21 M | $67.21 M(-416.0%) | $181.21 M(-180.2%) |
Sep 2021 | - | -$21.27 M(-151.3%) | -$226.05 M(-25.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $41.45 M(-55.8%) | -$302.03 M(+82.0%) |
Mar 2021 | - | $93.82 M(-127.6%) | -$165.98 M(+41.8%) |
Dec 2020 | -$117.04 M(-75.7%) | -$340.05 M(+249.7%) | -$117.04 M(-143.4%) |
Sep 2020 | - | -$97.25 M(-154.8%) | $269.69 M(+154.2%) |
Jun 2020 | - | $177.49 M(+24.3%) | $106.08 M(-190.9%) |
Mar 2020 | - | $142.76 M(+205.8%) | -$116.76 M(-75.8%) |
Dec 2019 | -$481.70 M(<-9900.0%) | $46.68 M(-117.9%) | -$481.70 M(-3.8%) |
Sep 2019 | - | -$260.85 M(+475.2%) | -$500.75 M(+113.3%) |
Jun 2019 | - | -$45.35 M(-79.6%) | -$234.76 M(+27.1%) |
Mar 2019 | - | -$222.18 M(-904.1%) | -$184.75 M(<-9900.0%) |
Dec 2018 | $736.00 K(-98.0%) | $27.63 M(+438.3%) | $736.00 K(-102.7%) |
Sep 2018 | - | $5.13 M(+10.1%) | -$26.89 M(-16.0%) |
Jun 2018 | - | $4.66 M(-112.7%) | -$32.03 M(-12.7%) |
Mar 2018 | - | -$36.69 M | -$36.69 M |
Dec 2017 | $36.43 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual cash flow from investing activities?
- What is the all time high annual CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual CFI year-on-year change?
- What is Adaptive Biotechnologies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly CFI year-on-year change?
- What is Adaptive Biotechnologies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM CFI year-on-year change?
What is Adaptive Biotechnologies annual cash flow from investing activities?
The current annual CFI of ADPT is $77.79 M
What is the all time high annual CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash flow from investing activities is $181.21 M
What is Adaptive Biotechnologies annual CFI year-on-year change?
Over the past year, ADPT annual cash flow from investing activities has changed by -$51.85 M (-40.00%)
What is Adaptive Biotechnologies quarterly cash flow from investing activities?
The current quarterly CFI of ADPT is $22.12 M
What is the all time high quarterly CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash flow from investing activities is $177.49 M
What is Adaptive Biotechnologies quarterly CFI year-on-year change?
Over the past year, ADPT quarterly cash flow from investing activities has changed by +$16.83 M (+318.37%)
What is Adaptive Biotechnologies TTM cash flow from investing activities?
The current TTM CFI of ADPT is $77.79 M
What is the all time high TTM CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM cash flow from investing activities is $269.69 M
What is Adaptive Biotechnologies TTM CFI year-on-year change?
Over the past year, ADPT TTM cash flow from investing activities has changed by +$18.91 M (+32.12%)